4/24
07:10 am
rdhl
RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study [Yahoo! Finance]
Medium
Report
RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study [Yahoo! Finance]
4/24
07:00 am
rdhl
RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study
Low
Report
RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study
4/18
02:03 am
rdhl
RedHill Biopharma Ltd. (NASDAQ: RDHL) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Medium
Report
RedHill Biopharma Ltd. (NASDAQ: RDHL) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
4/10
06:43 am
rdhl
RedHill Biopharma Full Year 2023 Earnings: EPS: US$4.00 (vs US$46.29 loss in FY 2022) [Yahoo! Finance]
Medium
Report
RedHill Biopharma Full Year 2023 Earnings: EPS: US$4.00 (vs US$46.29 loss in FY 2022) [Yahoo! Finance]
4/8
05:31 pm
rdhl
Giant-Cell Arteritis Market to Showcase Positive Growth at a CAGR of 9.3% by 2034 | DelveInsight
Medium
Report
Giant-Cell Arteritis Market to Showcase Positive Growth at a CAGR of 9.3% by 2034 | DelveInsight
4/8
05:31 pm
rdhl
Giant-Cell Arteritis Market to Showcase Positive Growth at a CAGR of 9.3% by 2034 | DelveInsight
Medium
Report
Giant-Cell Arteritis Market to Showcase Positive Growth at a CAGR of 9.3% by 2034 | DelveInsight
4/8
09:35 am
rdhl
RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights [Yahoo! Finance]
Low
Report
RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights [Yahoo! Finance]
4/8
09:23 am
rdhl
RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights
Low
Report
RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights
4/2
07:23 am
rdhl
RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market Price [Yahoo! Finance]
Low
Report
RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market Price [Yahoo! Finance]
4/2
07:00 am
rdhl
RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market Price
Low
Report
RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market Price
4/2
02:05 am
rdhl
RedHill Biopharma Ltd. (NASDAQ: RDHL) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Medium
Report
RedHill Biopharma Ltd. (NASDAQ: RDHL) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
3/11
07:35 am
rdhl
RedHill Announces New USPTO Patent Covering Talicia® Through 2034 [Yahoo! Finance]
Low
Report
RedHill Announces New USPTO Patent Covering Talicia® Through 2034 [Yahoo! Finance]
3/11
07:00 am
rdhl
RedHill Announces New USPTO Patent Covering Talicia® Through 2034
Low
Report
RedHill Announces New USPTO Patent Covering Talicia® Through 2034
3/7
11:15 am
rdhl
Pharmaceuticals and Biotechnology Co-promotion and Co-marketing Partnering Trends Report 2024: Analysis of Deals Signed by the World's Leading Life Science Companies Signed Since 2016
Low
Report
Pharmaceuticals and Biotechnology Co-promotion and Co-marketing Partnering Trends Report 2024: Analysis of Deals Signed by the World's Leading Life Science Companies Signed Since 2016
3/5
07:18 am
rdhl
RedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures Programs [Yahoo! Finance]
High
Report
RedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures Programs [Yahoo! Finance]
3/5
07:00 am
rdhl
RedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures Programs
Medium
Report
RedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures Programs
2/28
02:12 pm
rdhl
Antiemetic Drug Market size is to grow by USD 1.63 billion, The increasing healthcare expenditure to boost market growth, Technavio
Low
Report
Antiemetic Drug Market size is to grow by USD 1.63 billion, The increasing healthcare expenditure to boost market growth, Technavio
2/20
07:08 am
rdhl
RedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New Publication [Yahoo! Finance]
Medium
Report
RedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New Publication [Yahoo! Finance]
2/20
07:00 am
rdhl
RedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New Publication
High
Report
RedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New Publication
1/26
12:52 pm
rdhl
RedHill Biopharma Announces Closing of $8 Million Registered Direct Offering [Yahoo! Finance]
Low
Report
RedHill Biopharma Announces Closing of $8 Million Registered Direct Offering [Yahoo! Finance]
1/26
12:46 pm
rdhl
RedHill Biopharma Announces Closing of $8 Million Registered Direct Offering
Low
Report
RedHill Biopharma Announces Closing of $8 Million Registered Direct Offering
1/25
09:08 am
rdhl
RedHill Biopharma Announces $8 Million Registered Direct Offering [Yahoo! Finance]
High
Report
RedHill Biopharma Announces $8 Million Registered Direct Offering [Yahoo! Finance]
1/25
09:05 am
rdhl
RedHill Biopharma Announces $8 Million Registered Direct Offering
High
Report
RedHill Biopharma Announces $8 Million Registered Direct Offering
1/25
06:12 am
rdhl
RedHill Announces New USPTO Patent Grant for Talicia® for H. pylori Treatment Through 2042 [Yahoo! Finance]
High
Report
RedHill Announces New USPTO Patent Grant for Talicia® for H. pylori Treatment Through 2042 [Yahoo! Finance]
1/25
06:00 am
rdhl
RedHill Announces New USPTO Patent Grant for Talicia® for H. pylori Treatment Through 2042
High
Report
RedHill Announces New USPTO Patent Grant for Talicia® for H. pylori Treatment Through 2042